Skeletal muscle carnosine content can be increased through β-alanine (BA) supplementation, but the maximum increase achievable with supplementation is unknown. No study has investigated the effects of prolonged supplementation on carnosine-related genes or exercise capacity.Purpose
This study aimed to investigate the effects of 24 wk of BA supplementation on muscle carnosine content, gene expression, and high-intensity cycling capacity (CCT110%).Methods
Twenty-five active males were supplemented with 6.4 g·d−1 of sustained release BA or placebo for a 24 wk period. Every 4 wk participants provided a muscle biopsy and performed the CCT110%. Biopsies were analyzed for muscle carnosine content and gene expression (CARNS, TauT, ABAT, CNDP2, PHT1, PEPT2, and PAT1).Results
Carnosine content was increased from baseline at every time point in BA (all P < 0.0001; week 4 = +11.37 ± 7.03 mmol·kg−1 dm, week 8 = +13.88 ± 7.84 mmol·kg−1 dm, week 12 = +16.95 ± 8.54 mmol·kg−1 dm, week 16 = +17.63 ± 8.42 mmol·kg−1 dm, week 20 = +21.20 ± 7.86 mmol·kg−1 dm, and week 24 = +20.15 ± 7.63 mmol·kg−1 dm) but not placebo (all P > 0.05). Maximal increases were +25.66 ± 7.63 mmol·kg−1 dm (range = +17.13 to +41.32 mmol·kg−1 dm), and absolute maximal content was 48.03 ± 8.97 mmol·kg−1 dm (range = 31.79 to 63.92 mmol·kg−1 dm). There was an effect of supplement (P = 0.002) on TauT; no further differences in gene expression were shown. Exercise capacity was improved in BA (P = 0.05) with possible to almost certain improvements across all weeks.Conclusions
Twenty-four weeks of BA supplementation increased muscle carnosine content and improved high-intensity cycling capacity. The downregulation of TauT suggests it plays an important role in muscle carnosine accumulation with BA supplementation, whereas the variability in changes in muscle carnosine content between individuals suggests that other determinants other than the availability of BA may also bear a major influence on muscle carnosine content.